《大行報告》大摩:小鵬(09868.HK)新車G6定價進取 軟硬件功能可與同業競爭
摩根士丹利發表研究報告指,小鵬(09868.HK)新車G6的定價為20.99萬元人民幣,與預售時的22.5萬元人民幣相比更具競爭力。集團更積極的定價策略和具競爭力的軟硬件功能將令G6能夠與同行競爭,有效的訂單轉換和平穩的產量提升是G6上行的關鍵。
該行認為,雖然現在斷言G6能夠扭轉局勢仍為時過早,但相信與G9和P5相比,更好的產品發布和更精確的價值主張應該有助於恢復市場對小鵬汽車硬件的信心,並使投資者更願意將部分注意力轉移到其汽車硬件上。
該行予集團「增持」評級,目標價12.5美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.